Readmission Risk Factors and Heart Failure With Preserved Ejection Fraction

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

492 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-08-01

Study Completion Date

2019-01-18

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Retrospective review of 492 patient from a small community hospital who did not qualify for participation in the Connect HF study sponsored by DCRI.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Readmission in the Case of Patients With Heart Failure

NCT02808221

Heart Failure

UNKNOWN

An Observational Study of the Functional Capacity of Heart Failure

NCT02350114

Acute Heart Failure

COMPLETED NA

Effect of Post Discharge Follow-up on Readmission Rates for Congestive Heart Failure Patients

NCT01529463

Congestive Heart Failure Systolic Dysfunction

COMPLETED

Outcome of Discharged HFmrEF Patients

NCT05240118

Heart Failure With Mid Range Ejection Fraction

COMPLETED

Prognostic Impact of Noncardiac Comorbidities in Heart Failure Patients

NCT02946476

Heart Failure, Diastolic Heart Failure, Systolic

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Retrospective review of adults above the age of 18 with a primary diagnosis of HFpEF between August 2017 and March 2018. Subjects had to fall into one of two classifications (NYHA Class II-IV or ACC/AHA Stage B-D) and had a life expectancy greater than 6 months are included. Individuals with a terminal illness other than HF, prior heart transplant or on a transplant list, or current/ planned left ventricular assist device excluded. The primary objective of this study is to identify risk factors for readmission in patients discharged with a diagnosis of HFpEF.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Heart Failure Preserved Ejection Fraction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

readmission at 30 days

retrospective observation

Intervention Type OTHER

Retrospective review of study patients excluded from the CONNECT- HF trial who were discharged with a diagnosis of HFpEF between August 1, 2017 and March 1, 2018. Readmission rate at 30 and 90 days along with patient demographics and associated comorbidities were analyzed.

readmission at 90 days

retrospective observation

Intervention Type OTHER

Retrospective review of study patients excluded from the CONNECT- HF trial who were discharged with a diagnosis of HFpEF between August 1, 2017 and March 1, 2018. Readmission rate at 30 and 90 days along with patient demographics and associated comorbidities were analyzed.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

retrospective observation

Retrospective review of study patients excluded from the CONNECT- HF trial who were discharged with a diagnosis of HFpEF between August 1, 2017 and March 1, 2018. Readmission rate at 30 and 90 days along with patient demographics and associated comorbidities were analyzed.

Intervention Type OTHER